Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 405949, 5 pages
http://dx.doi.org/10.1155/2015/405949
Review Article

Controversial Indications for Sentinel Lymph Node Biopsy in Breast Cancer Patients

1Department of Internal Medicine, American University of Beirut Medical Center, Cairo Street, P.O. Box 11-0236, Riad El Solh, Beirut 1107 2020, Lebanon
2Department of Surgery, American University of Beirut Medical Center, Cairo Street, P.O. Box 11-0236, Riad El Solh, Beirut 1107 2020, Lebanon
3Department of Medicine, Dalhousie University, 6299 South Street, Halifax, NS, Canada B3H 4R2

Received 21 November 2014; Revised 19 February 2015; Accepted 19 February 2015

Academic Editor: Robert A. Vierkant

Copyright © 2015 Hazem Assi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Göker, N. Devoogdt, G. van de Putte et al., “Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance,” Facts Views and Vision in Obgyn, vol. 5, no. 2, pp. 106–115, 2013. View at Google Scholar
  2. A. Fleissig, L. J. Fallowfield, C. I. Langridge et al., “Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer,” Breast Cancer Research and Treatment, vol. 95, no. 3, pp. 279–293, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Fisher, J.-H. Jeong, S. Anderson, J. Bryant, E. R. Fisher, and N. Wolmark, “Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation,” The New England Journal of Medicine, vol. 347, no. 8, pp. 567–575, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. A. E. Giuliano, D. M. Kirgan, J. M. Guenther, and D. L. Morton, “Lymphatic mapping and sentinel lymphadenectomy for breast cancer,” Annals of Surgery, vol. 220, no. 3, pp. 391–401, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. D. N. Krag, S. J. Anderson, T. B. Julian et al., “Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial,” The Lancet Oncology, vol. 11, no. 10, pp. 927–933, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. R. E. Mansel, L. Fallowfield, M. Kissin et al., “Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial,” Journal of the National Cancer Institute, vol. 98, no. 9, pp. 599–609, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. E. Giuliano, K. K. Hunt, K. V. Ballman et al., “Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial,” Journal of the American Medical Association, vol. 305, no. 6, pp. 569–575, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. E. Giuliano, L. McCall, P. Beitsch et al., “Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases. The American College of Surgeons Oncology Group Z0011 randomized trial,” Annals of Surgery, vol. 252, no. 3, pp. 426–432, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. D. Gobardhan, S. G. Elias, E. V. E. Madsen et al., “Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study,” Annals of Surgical Oncology, vol. 18, no. 6, pp. 1657–1664, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. N. M. Hansen, B. Grube, X. Ye et al., “Impact of micrometastases in the sentinel node of patients with invasive breast cancer,” Journal of Clinical Oncology, vol. 27, no. 28, pp. 4679–4684, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C. E. Cox, J. V. Kiluk, A. I. Riker et al., “Significance of sentinel lymph node micrometastases in human breast cancer,” Journal of the American College of Surgeons, vol. 206, no. 2, pp. 261–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. L. K. Tan, D. Giri, A. J. Hummer et al., “Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up,” Journal of Clinical Oncology, vol. 26, no. 11, pp. 1803–1809, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. E. Giuliano, D. Hawes, K. V. Ballman et al., “Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer,” The Journal of the American Medical Association, vol. 306, no. 4, pp. 385–393, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. T. B. Julian, S. J. Anderson, D. N. Krag et al., “10-yr follow-up results of occult detected sentinel node disease: NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients,” in Proceedings of the San Antonio Breast Cancer Symposium, Abstract S2-05, San Antonio, Tex, USA, 2013.
  15. A. S. Caudle, K. K. Hunt, S. L. Tucker et al., “American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns,” Annals of Surgical Oncology, vol. 19, no. 10, pp. 3144–3151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. M. Gainer, K. K. Hunt, P. Beitsch, A. S. Caudle, E. A. Mittendorf, and A. Lucci, “Changing behavior in clinical practice in response to the ACOSOG Z0011 trial: a survey of the American Society of Breast Surgeons,” Annals of Surgical Oncology, vol. 19, no. 10, pp. 3152–3158, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Galimberti, B. F. Cole, S. Zurrida et al., “Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial,” The Lancet Oncology, vol. 14, no. 4, pp. 297–305, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. D. J. Rutgers, M. Donker, M. E. Straver, P. Meijnen, C. J. H. van de Velde, and R. E. Mansel, “Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: final analysis of the EORTC AMAROS trial (10981/22023),” Journal of Clinical Oncology, vol. 31, no. 15, supplement, Article ID LBA1001, 2013. View at Google Scholar
  19. W. Janni, T. Kühn, L. Schwentner, R. Kreienberg, T. Fehm, and A. Wöckel, “Sentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits,” Deutsches Ärzteblatt International, vol. 111, no. 14, pp. 244–249, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. J. C. Boughey, V. J. Suman, E. A. Mittendorf et al., “Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (alliance) clinical trial,” The Journal of the American Medical Association, vol. 310, no. 14, pp. 1455–1461, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Xing, M. Foy, D. D. Cox, H. M. Kuerer, K. K. Hunt, and J. N. Cormier, “Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer,” British Journal of Surgery, vol. 93, no. 5, pp. 539–546, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. W.-K. Ge, B. Yang, W.-S. Zuo et al., “Sentinel lymph node biopsy does not apply to all axillary lymph node-positive breast cancer patients after neoadjuvant chemotherapy,” Thoracic Cancer, vol. 5, no. 6, pp. 550–555, 2014. View at Publisher · View at Google Scholar
  23. T. Kuehn, I. Bauerfeind, T. Fehm et al., “Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study,” The Lancet Oncology, vol. 14, no. 7, pp. 609–618, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J.-F. Fu, H.-L. Chen, J. Yang, C.-H. Yi, and S. Zheng, “Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast sancer after neoadjuvant chemotherapy: a meta-analysis,” PLoS ONE, vol. 9, no. 9, Article ID e105316, 2014. View at Publisher · View at Google Scholar
  25. R. Piana, “Issues in the management of the axilla in patients with breast cancer,” ASCO Post, vol. 5, no. 10, 2014. View at Google Scholar
  26. I. L. Wapnir, S. J. Anderson, E. P. Mamounas et al., “Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five national surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials,” Journal of Clinical Oncology, vol. 24, no. 13, pp. 2028–2037, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. J. Anderson, I. Wapnir, J. J. Dignam et al., “Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer,” Journal of Clinical Oncology, vol. 27, no. 15, pp. 2466–2473, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. S. Kothari, J. E. Rusby, A. A. Agusti, and F. A. MacNeill, “Sentinel lymph node biopsy after previous axillary surgery: a review,” European Journal of Surgical Oncology, vol. 38, no. 1, pp. 8–15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. A. J. G. Maaskant-Braat, A. C. Voogd, R. M. H. Roumen, and G. A. P. Nieuwenhuijzen, “Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature,” Breast Cancer Research and Treatment, vol. 138, no. 1, pp. 13–20, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. A. J. G. Maaskant-Braat, R. M. H. Roumen, A. C. Voogd et al., “Sentinel node and recurrent breast cancer (SNARB): results of a nationwide registration study,” Annals of Surgical Oncology, vol. 20, no. 2, pp. 620–626, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Taback, P. Nguyen, N. Hansen, G. K. Edwards, K. Conway, and A. E. Giuliano, “Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy,” Annals of Surgical Oncology, vol. 13, no. 8, pp. 1099–1104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. D. M. Black and E. A. Mittendorf, “Landmark trials affecting the surgical management of invasive breast cancer,” Surgical Clinics of North America, vol. 93, no. 2, pp. 501–518, 2013. View at Publisher · View at Google Scholar · View at Scopus